This inventor holds 5 USPTO granted patents. Top assignee: Cubist Pharmaceuticals, Incorporated. Active years: 1998-2001.
Company Filing History:
Years Active: 1998-2001
Title: The Innovative Work of Mandana Sassanfar in Biotechnology
Introduction: Mandana Sassanfar, a talented inventor based in Dedham, MA, has made significant contributions to the field of biotechnology with his inventive patents and research. With a total of 5 patents to his name, his work focuses on the development of nucleic acids encoding aminoacyl-tRNA synthetases of microbial origin, particularly in enterococci and Candida species.
Latest Patents:
1. Enterococcal aminoacyl-trna synthetase proteins, nucleic acids and strains: Sassanfar's groundbreaking patent involves the isolation of nucleic acids encoding enterococcal aminoacyl-tRNA synthetases. These nucleic acids are utilized in the production of recombinant enzymes and can aid in drug testing through engineered tester strains.
2. Candida isoleucyl-tRNA synthetase proteins, nucleic acids and strains: Another key patent by Sassanfar focuses on Candida isoleucyl-tRNA synthetases, their encoding nucleic acids, and related constructs. This invention opens up possibilities for drug development and novel research avenues in the field.
Career Highlights: Mandana Sassanfar is associated with Cubist Pharmaceuticals, Incorporated, where he continues to drive innovation and pioneering research in the biotechnology sector. His expertise and dedication have led to the successful development and implementation of novel technologies in the industry.
Collaborations: Throughout his career, Sassanfar has collaborated with esteemed professionals in the field, including coworkers such as Paul L Gallant and Paul R Schimmel. These collaborations have enriched his research endeavors and brought forth new perspectives to his innovative work.
Conclusion: Mandana Sassanfar's groundbreaking research and inventive patents in biotechnology stand as a testament to his dedication and passion for advancing scientific knowledge. His contributions not only expand the realm of possibilities in the field but also pave the way for future innovations in biotechnology.